NAS
VERA icon

Nykredit A/S’s Vera Therapeutics VERA Stock Holding History

Nykredit A/S’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.1K Buy
+2,264
New +$84.4K ﹤0.01% 1327

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Nykredit A/S's VERA Position: Q2 2026 in Review

Nykredit A/S opened a new position in Vera Therapeutics (VERA) in Q2 2026: 2,264 shares worth $97.1K. The stake represents ﹤0.01% of the portfolio and ranks #1327 among its holdings.

129 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Nykredit A/S held 2,264 shares of Vera Therapeutics worth $97.1K as of Q2 2026.
  • Vera Therapeutics was a new Nykredit A/S position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1327 holding.
  • 129 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.